- Home
- BBIO vs SKYW Comparison
BBIO vs SKYW Comparison
Compare BBIO & SKYW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BBIO
- SKYW
- Stock Information
- Founded
- BBIO 2015
- SKYW 1972
- Country
- BBIO United States
- SKYW United States
- Employees
- BBIO N/A
- SKYW N/A
- Industry
- BBIO Biotechnology: Pharmaceutical Preparations
- SKYW Air Freight/Delivery Services
- Sector
- BBIO Health Care
- SKYW Consumer Discretionary
- Exchange
- BBIO Nasdaq
- SKYW Nasdaq
- Market Cap
- BBIO 8.0B
- SKYW 4.1B
- IPO Year
- BBIO 2019
- SKYW N/A
- Fundamental
- Price
- BBIO $43.40
- SKYW $107.78
- Analyst Decision
- BBIO Strong Buy
- SKYW Strong Buy
- Analyst Count
- BBIO 14
- SKYW 3
- Target Price
- BBIO $58.85
- SKYW $120.67
- AVG Volume (30 Days)
- BBIO 3.3M
- SKYW 269.3K
- Earning Date
- BBIO 07-31-2025
- SKYW 07-24-2025
- Dividend Yield
- BBIO N/A
- SKYW N/A
- EPS Growth
- BBIO N/A
- SKYW 219.12
- EPS
- BBIO N/A
- SKYW 8.74
- Revenue
- BBIO $127,415,000.00
- SKYW $3,672,761,000.00
- Revenue This Year
- BBIO $102.05
- SKYW $12.13
- Revenue Next Year
- BBIO $54.69
- SKYW $5.21
- P/E Ratio
- BBIO N/A
- SKYW $12.33
- Revenue Growth
- BBIO N/A
- SKYW 20.53
- 52 Week Low
- BBIO $21.72
- SKYW $64.61
- 52 Week High
- BBIO $45.48
- SKYW $135.57
- Technical
- Relative Strength Index (RSI)
- BBIO 63.17
- SKYW 67.08
- Support Level
- BBIO $41.80
- SKYW $102.63
- Resistance Level
- BBIO $45.48
- SKYW $101.00
- Average True Range (ATR)
- BBIO 1.51
- SKYW 2.56
- MACD
- BBIO -0.08
- SKYW 0.79
- Stochastic Oscillator
- BBIO 63.36
- SKYW 95.39
About BBIO BridgeBio Pharma Inc.
BridgeBio Pharma is a biotechnology company focused on discovering, developing, testing, and delivering transformative treatments for patients with genetic diseases. The company has four programs in its late-stage pipeline focusing on Mendelian disorders, oncology, and gene therapy. One of its key programs, Attruby (acoramidis) , is an orally administered small molecule designed to stabilize tetrameric transthyretin for the treatment of transthyretin amyloid cardiomyopathy.
About SKYW SkyWest Inc.
SkyWest Inc offers commercial air services in the United States, Canada, Mexico, and the Caribbean. Additionally, it leases aircraft to capable users to help generate revenue. Generally, SkyWest provides regional flights, and utilizes its smaller, lower-cost aircraft to carry passengers that booked tickets through airlines. It partners with carriers across the world to fly and operate aircraft for a fee. SkyWest may use the carriers's brand and ground support to coordinate marketing and easily transport passengers. The company has two reportable segments: SkyWest Airlines, which generates maximum revenue, and SkyWest Leasing.